1. Whether the panel erred in “focusing on design changes allegedly required for bodily incorporation” in determining obviousness.
2. Whether the panel’s apportionment analysis departs from the Supreme Court’s requirement that “patent owners ‘must in every case give evidence tending to separate or apportion the defendant’s profits and the patentee’s damages between the patented feature and the unpatented features.’”
